- Companies
- Scivita Medical Technology
Scivita Medical Technology Valuation, Funding & Investors
Scivita Medical Technology is valued at $1.1B as of August 2021.
Last Scivita Medical Technology valuation
$1.1B
Series B · Aug 2021
Last Scivita Medical Technology funding round
$62M
Series B · Aug 2021
Cumulative funding Scivita Medical Technology raised
$123M
across 2 funding rounds
Key investors in Scivita Medical Technology
Matrix Partners China
Lilly Asia Ventures
GL Ventures LLC
Medtronic
Chengwei Capital
Inno-Chip
About Scivita Medical Technology
Scivita Medical Technology is a medical device manufacturer specializing in advanced endoscopy systems for minimally invasive diagnostics and surgery. Its portfolio includes 4K ultra-high-definition endoscopes, 3D visualization platforms, narrow-band imaging for fluorescence, and single-use disposable scopes covering flexible and rigid formats. Headquartered in Hangzhou, China, the firm holds certifications from China's NMPA and exports to over 50 countries. Scivita supplies products to hospitals in gastroenterology, urology, and ENT fields, with notable deployments in Asia-Pacific surgical centers.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Valuation
$1.1B (Aug 2021)
Scivita Medical Technology Valuation
Scivita Medical Technology is currently valued at $1.1B, based on its Series B in August 2021.
The $62M round included Matrix Partners China, Prime Capital, GL Ventures LLC, Hudson Bay Capital Management and Lilly Asia Ventures.
Scivita Medical Technology valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Aug 2021 | Series B | $1.1B |
Scivita Medical Technology Funding History
Scivita Medical Technology has raised a total of $123M across 2 funding rounds.
Scivita Medical Technology's first fundraising round was a $61M Series A in April 2021. The most recent completed round was a $62M Series B in August 2021.
Scivita Medical Technology funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Aug 2021 | Series B | Matrix Partners China; Prime Capital; GL Ventures LLC; Hudson Bay Capital Management; Lilly Asia Ventures | $62M | $1.1B | Scivita Medical Technology Co., Ltd., founded in 2016, is a high-tech medical device company specializing in minimally invasive vision solutions, particularly in endoscopes and related technologies such as ultra-high-definition 4K UHD visualization, 3D imaging, fluorescence imaging, and single-use endoscopic consumables. Headquartered in Suzhou Industrial Park, China, with an R&D center in Tokyo, Japan, the company focuses on optical diagnosis, multidimensional imaging, high-performance materials, and precision manufacturing for both flexible and rigid endoscopy applications. The Series B funding round occurred on August 5, 2021, raising $61.91 million from investors including GL Ventures, Hudson Bay Capital Management, Lilly Asia Ventures, Matrix Partners China (MPC), and Prime Capital. This followed a Series A round on April 26, 2021, securing nearly 400 million yuan (approximately $61 million USD) led by GL Ventures and Lilly Asia Ventures, with participation from Matrix Partners China, Medtronic, Chengwei Capital, and Shanghai Innochip Investment. Scivita Medical has achieved key regulatory milestones around this period, including FDA clearance for its 4K UHD Laparoscope in February 2021, NMPA and CE approvals for products like 3D visualization systems, single-use hysteroscopes, choledochoscopes, and urology videoscopes, and PMDA approval for single-use urology videoscopes. The company entered a strategic partnership with Medtronic and acquired Japanese firm ARS, positioning it as a leader in China for 3D and 4K UHD endoscopy with global penetration in America, Europe, and Asia. Scivita was recognized as a potential unicorn by Greatwall Strategy Consultants in 2021 and received awards like the China Medical Equipment Excellence List in 2022, reflecting strong market validation in high-performance endoscopic technologies amid growing demand for disposable endoscopes and emerging endoscopy innovations. |
| Apr 2021 | Series A | GL Ventures LLC (lead); Lilly Asia Ventures (lead); Matrix Partners China; Medtronic; Chengwei Capital; Inno-Chip | $61M | - | Scivita Medical Technology raised funding across multiple rounds in 2021 to support its global expansion strategy. The company completed a Series B financing round on August 5, 2021, raising $61.91M USD with investors including GL Ventures, Hudson Bay Capital Management, Lilly Asia Ventures, MPC, and Prime Capital. An earlier Series A round occurred on April 26, 2021. The company also announced receipt of nearly RMB 0.4 billion (approximately $61.4M USD) in Series B financing with involvement from international investors. |
Who has invested in Scivita Medical Technology?
8 investors have backed Scivita Medical Technology across its funding rounds, including Matrix Partners China, Lilly Asia Ventures, GL Ventures LLC, Medtronic, Chengwei Capital and Inno-Chip.
Lead investors include GL Ventures LLC and Lilly Asia Ventures.
Scivita Medical Technology Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | Apr 2021 | ||
| 2 | Lead | Apr 2021 | ||
| 2 | Lead | Apr 2021 | ||
| 1 | Participant | Aug 2021 | ||
| 1 | Participant | Apr 2021 | ||
| 1 | Participant | Apr 2021 | ||
This data is available for Pro users. Sign up to see all 8 Scivita Medical Technology investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialScivita Medical Technology Competitors
Scivita Medical Technology competitors include listed companies like UltraGreen.ai, Wandong Medical, SonoScape and Sinocare, and private ones like Carestream and SiBionics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $800M | - | ||
| Private | - | - | $717M | - | ||
| Publicly listed | $138M | $78M | $672M | 2.9x | ||
| Publicly listed | $201M | ($46M) | $1B | 3.2x | ||
| Publicly listed | $344M | $35M | $1.2B | 2.8x | ||
| Publicly listed | $695M | $43M | $1.3B | 1.8x |
Scivita Medical Technology Public Comps
Scivita Medical Technology is still privately-owned, but its public comps include iRadimed, Staar Surgical, Clinica Baviera, Wandong Medical, Obsidian Therapeutics, Enovis, Shinva, PHC Holdings, Guangzhou Wondfo Biotech and Daan Gene.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $84M | $28M | 11.9x | 11.2x | 36.3x | 32.8x | |||
| $239M | ($37M) | 3.8x | 3.0x | (24.7x) | 21.5x | |||
| $348M | $98M | 2.9x | 2.7x | 10.3x | 9.4x | |||
| $201M | ($46M) | 3.1x | 3.2x | (13.7x) | - | |||
| - | ($104M) | - | - | (13.0x) | - | |||
| $2.2B | ($830M) | 1.1x | 1.0x | (2.9x) | 5.7x | |||
| $1.5B | $126M | 0.6x | 0.6x | 6.7x | 6.7x | |||
| $2.3B | $320M | 1.0x | 1.0x | 7.2x | 6.5x | |||
This data is available for Pro users. Sign up to see all Scivita Medical Technology competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Scivita Medical Technology
| When was Scivita Medical Technology founded? | Scivita Medical Technology was founded in 2016. |
| Where is Scivita Medical Technology headquartered? | Scivita Medical Technology is headquartered in Suzhou, China. |
| Is Scivita Medical Technology publicly listed? | No, Scivita Medical Technology is a private, VC-backed company. |
| What is Scivita Medical Technology's valuation? | Scivita Medical Technology was last valued at $1.1B in its Series B in August 2021. |
| How much funding has Scivita Medical Technology raised? | Scivita Medical Technology has raised $123M across 2 funding rounds. |
| What was Scivita Medical Technology's last funding round? | Scivita Medical Technology's last funding round was a $62M Series B in August 2021. |
| Who are Scivita Medical Technology's investors? | Scivita Medical Technology's investors include Matrix Partners China, GL Ventures LLC, Lilly Asia Ventures, Prime Capital, Medtronic, Chengwei Capital, Hudson Bay Capital Management and Inno-Chip. |
| Which companies are comparable to Scivita Medical Technology? | Companies comparable to Scivita Medical Technology include Carestream, SiBionics, UltraGreen.ai, Wandong Medical, SonoScape and Sinocare. |
See companies similar to Scivita Medical Technology
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




